13:47:45 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-17 Bokslutskommuniké 2024
2024-11-08 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-06-07 Ordinarie utdelning POLYMER 0.00 SEK
2024-06-05 Årsstämma 2024
2024-05-08 Kvartalsrapport 2024-Q1
2024-02-16 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-08-16 Kvartalsrapport 2023-Q2
2023-06-05 Ordinarie utdelning POLYMER 0.00 SEK
2023-06-02 Årsstämma 2023
2023-05-10 Kvartalsrapport 2023-Q1
2023-02-15 Extra Bolagsstämma 2023
2023-02-10 Bokslutskommuniké 2022
2022-11-10 Kvartalsrapport 2022-Q3
2022-08-10 Kvartalsrapport 2022-Q2
2022-06-09 Ordinarie utdelning POLYMER 0.00 SEK
2022-06-08 Årsstämma 2022
2022-05-10 Kvartalsrapport 2022-Q1
2022-02-25 Bokslutskommuniké 2021
2021-12-20 Extra Bolagsstämma 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-03 Årsstämma 2021
2021-05-25 Kvartalsrapport 2021-Q1

Beskrivning

LandSverige
ListaSpotlight
SektorMaterial
IndustriPlast, kemikalier & fetter
Polymer Factory Sweden är specialiserade inom nanoteknologi. Bolaget utvecklar polymera material som används i diverse medicinska behandlingar. Lösningarna används huvudsakligen som komplement i olika behandlingar för cancer och neurologiska sjukdomar. Utöver huvudverksamheten erbjuder bolag kalibreringsteknik som används i olika analyser- och livsmedelstestning.
2022-12-06 13:57:53

Polymer Factory Sweden AB announces the launch of the new dendritic platform Dendritic Nanogels (DNG). Through the launch of this platform, the Company fulfills an operational objective set out for 2022.

On December 1[st], Polymer Factory launched the company's latest dendritic platform, DNG. This is a nanocarrier platform with the potential use as delivery vehicles of pharmaceuticals, peptides, antibiotics etc. It is a novel platform of crosslinked nanoparticles, with features such as water solubility, biocompatibility, and degradability. The DNGs can be programmed to embed functionality and thereby allow them to act as nanoscopic delivery system of therapeutics, fragrances, peptides, and other organic molecules. The DNG technology is envisioned to be desired by different industries, particularly for therapeutic, biomedical and industrial use.

Polymer Factory has pending patents protecting the novel DNG technology.

CTO Michael Malkoch comments:

"We are excited to launch the first generation of DNGs as a new product line of nanocarriers. Our DNGs are unique in the sense of being available as stable and ready-to-formulate products suited to encapsulate and deliver drugs, peptides, biologics and much more. This will allow our customers to straightforwardly screen the performance of their desired active compounds without a large investment in formulation optimization. With this in mind, it's my belief that the DNG platform can be a contender to the limited number of available delivery platforms such as Lipidic Nanoparticles (LNPs) and Liposomes."